Aditxt, Inc. Shares Outstanding (Cover Page)
Aditxt, Inc. (ADTX) had Shares Outstanding (Cover Page) of 815.92 thousand shares as of 2026-05-20, per its 10-Q filed 2026-05-20.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-05-20
- 2026-05-20: Entity Common Stock, Shares Outstanding 815.92K shares.
- 2026-03-30: Entity Common Stock, Shares Outstanding 904.47K shares.
- 2025-11-17: Entity Common Stock, Shares Outstanding 559.44K shares.
- 2025-08-13: Entity Common Stock, Shares Outstanding 4.98M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-05-20 | 815.92K shares 10-Q · filed 2026-05-20 |
| 2026-03-30 | 904.47K shares 10-K · filed 2026-03-31 |
| 2025-11-17 | 559.44K shares 10-Q · filed 2025-11-18 |
| 2025-08-13 | 4.98M shares 10-Q · filed 2025-08-14 |
| 2025-05-15 | 2.12M shares 10-Q · filed 2025-05-15 |
| 2025-03-28 | 1.16M shares 10-K · filed 2025-03-31 |
| 2024-11-13 | 14.23M shares 10-Q · filed 2024-11-18 |
| 2024-08-16 | 3.60M shares 10-Q · filed 2024-08-19 |
| 2024-05-17 | 1.67M shares 10-Q · filed 2024-05-20 |
| 2024-04-12 | 1.67M shares 10-K · filed 2024-04-16 |
| 2023-11-13 | 441.85K shares 10-Q · filed 2023-11-14 |
| 2023-08-11 | 7.61M shares 10-Q · filed 2023-08-14 |
| 2023-05-15 | 6.76M shares 10-Q · filed 2023-05-15 |
| 2023-04-26 | 5.88M shares 10-K/A · filed 2023-07-12 |
| 2023-04-14 | 4.83M shares 10-K · filed 2023-04-17 |
| 2022-11-11 | 4.16M shares 10-Q · filed 2022-11-14 |
| 2022-08-14 | 56.85M shares 10-Q · filed 2022-08-15 |
| 2022-05-13 | 44.73M shares 10-Q · filed 2022-05-16 |
| 2022-03-29 | 44.71M shares 10-K/A · filed 2022-04-15 |
| 2021-11-12 | 26.93M shares 10-Q · filed 2021-11-15 |
| 2021-08-11 | 14.69M shares 10-Q · filed 2021-08-12 |
| 2021-05-11 | 14.55M shares 10-Q · filed 2021-05-12 |
| 2021-03-24 | 14.12M shares 10-K · filed 2021-03-25 |
| 2020-11-11 | 12.28M shares 10-Q · filed 2020-11-13 |
| 2020-08-12 | 6.98M shares 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |